Overview

Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of celecoxib versus sodium diclofenac in subjects with acute low back pain
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Celecoxib
Diclofenac